Search Results

You searched for : cardiometabolic  

Heart-Healthy Dietary Patterns: Clinical Nutrition into Daily Meals

Modern cardiovascular nutrition has shifted away from restrictive, nutrient-focused rules toward balanced, evidence-based dietary patterns that support overall heart health. Current research emphasizes ...
Jun 15

Can Ice Cream Really Lower Diabetes Risk: Why Some Studies Keep Reporting a Result That Makes No Sense

Unexpected findings can open new lines of inquiry. The history of nutrition research is filled with examples where anomalies eventually led to deeper understanding....
Mar 13

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

In a key secondary endpoint, participants on orforglipron 36 mg lost 19.7 lbs (8.9 kg ;9.2%) compared to 11.0 lbs (5 ...
Feb 28

Agilus Diagnostics Launches India’s Most Comprehensive Vital Shape Test Suite for Obesity and Metabolic Health

Agilus Diagnostics, one of India’s leading diagnostic service providers and a subsidiary of Fortis Healthcare Ltd., today announced the launch of the Complete Care ...
Dec 04

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus

These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic dysregulation, inflammation, and renal progression in type 2 ...
Oct 31

Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ...
Oct 16

Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ...
Oct 15

Lilly's oral GLP-1, Orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity

Participants with obesity or overweight and type 2 diabetes, a population with increased difficulties losing weight, lost an average of 10.4 kg (10.5%) ...
Aug 28

HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025

HighTide Therapeutics, a clinical stage biopharmaceutical company specializing in the development of multifunctional multi-targeted therapies for chronic liver and metabolic diseases....
Apr 25

Berberine Ursodeoxycholate (HTD1801) Consistently Demonstrates Comprehensive Benefits for Patients with Type 2 Diabetes Mellitus, Approaching NDA

...
Apr 15

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies

Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)....
Sep 11

How a Fiber-Rich Diet and Gut Parasites Can Improve Your Health

The findings of this study open new avenues for exploring how the gut microbiome, including organisms like Blastocystis, influences our health....
Jul 16

HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress

Berberine Ursodeoxycholate (HTD1801) Provides a Unique Therapeutic Approach for Patients with Metabolic Liver Disease and Severe Insulin Resistance...
Jun 05

New Research Launched at BIO24 Finds CROs with In-house Regulatory Affairs Can Deliver 30% Savings, Halve Timelines and Cut Risks for Biotechs

here is a clear demand for a mid-sized, agile and responsive CRO with an in-house regulatory affairs team and a proven track record ...
Jun 04

Hypertension’s Effect on Diabetes and Heart Failure - Medicircle

Learn ways to deal with high blood tension, especially for people with hypertension in their families. Hypertension can lead to heart failure. But by implementing ...
May 16

Coffee may reduce risk of death from stroke and heart disease

The latest research on coffee suggests the results are not the same for normal and decaff coffee...
Aug 28

Could BeatO beat India's diabetes risk?

After their latest funding round in which BeatO successfully received Rs 42 crores, BeatO plans to increase its subscriber base. Will the diabetic care management ...
Aug 20

Low glycaemic diet shows meaningful improvements for people with diabetes

Benefits may go beyond what can be achieved with drugs or insulin alone ...
Aug 11

Green Mediterranean (‘green Med’) diet may be even better for health

Contains more plant matter plus green tea and Mankai (duckweed) than traditional version ...
Nov 25

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

...
Nov 19

A novel monoclonal antibody therapy cuts LDL cholesterol by half in a high-risk patient population,

In the USA, approximately 7 per cent of adults have been diagnosed with severe hypercholesterolemia, which is defined as having untreated LDL cholesterol at levels ...
Nov 18

The impact of ethnicity on clinical outcomes in COVID-19

After a systematic review to assess whether ethnicity has been reported in patients with COVID-19 and its relation to clinical outcomes....
Jun 06

Researchers in the US have more pieces of evidence that sitting can cause heart risk conditions.

Researchers show more evidences that sitting for longer durations can accelerate heart risk conditions....
Mar 04

Early detection of Diabetes and Hypertensive complains in pregnancy must, for avoiding future cardiometabolic daises

Improved education of healthcare providers and follow-up of women with hypertensive disorders and diabetes during pregnancy are needed to limit future risk of cardio ...
Nov 30

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Post-hoc analysis of the EMPA-REG OUTCOME® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ...
Sep 20

25 Matching result(s) found!

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026